首页> 外文期刊>Genetic testing and molecular biomarkers >Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays
【24h】

Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays

机译:通过整合microRNA和mRNA芯片筛选前列腺癌的生物标志物

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: In this study, we screened microRNA (miRNA) target genes of prostate cancer by integrating miRNA and mRNA expression profiles after target prediction and performed function enrichment analysis for selected candidate genes. Methods: The miRNA expression profile (GSE36802) and mRNA expression profile (GSE36801) were downloaded from the Gene Expression Omnibus database. We processed data and identified the differentially expressed miRNAs and mRNAs with R packages. Verified targets of miRNAs were identified through miRecods and miRTarBase. Then, software of Search Tool for the Retrieval of Interacting Genes was used to construct the interaction network of target genes. Finally, we performed function enrichment analysis for genes in the interaction network with the Functional Classification Tool. Results: A total of 22 upregulated and 8 down-regulated miRNAs were detected in this study, of which, hsa-mir-31 was the most overexpressed miRNA in prostate cancer. Both ITGA5 and RDX, two target genes of hsa-mir-31, were found to be differentially expressed from mRNA profiles by overexpressing hsa-mir-31. The cell adhesion molecule was found to be the most significant pathway enriched by ITGA5 and RDX. Conclusion: Overexpression of hsa-mir-31 can be a significant marker to distinguish cancer tissues from benign tissues. The targets such as ITGA5 and RDX regulated by hsa-mir-31 are candidate genes of prostate cancer, which provide new treatment strategies for its gene therapy.
机译:目的:在这项研究中,我们通过在目标预测后整合miRNA和mRNA表达谱来筛选前列腺癌的microRNA(miRNA)目标基因,并对选定的候选基因进行功能富集分析。方法:从Gene Expression Omnibus数据库下载miRNA表达谱(GSE36802)和mRNA表达谱(GSE36801)。我们处理了数据,并鉴定了带有R包装的差异表达的miRNA和mRNA。通过miRecods和miRTarBase鉴定了miRNA的验证靶标。然后,使用检索相互作用基因的搜索工具软件来构建靶基因的相互作用网络。最后,我们使用功能分类工具对相互作用网络中的基因进行了功能富集分析。结果:本研究共检测到22个上调的miRNA和8个下调的miRNA,其中hsa-mir-31是前列腺癌中最过量表达的miRNA。发现hsa-mir-31的两个靶基因ITGA5和RDX都通过过表达hsa-mir-31与mRNA谱差异表达。发现细胞粘附分子是ITGA5和RDX富集的最重要途径。结论:hsa-mir-31的过表达可能是区分癌组织与良性组织的重要标志。由hsa-mir-31调控的ITGA5和RDX等靶标是前列腺癌的候选基因,为其基因治疗提供了新的治疗策略。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2013年第11期|807-813|共7页
  • 作者单位

    Departments of Urology Second Affiliated Hospital, Third Military Medical University, Chongqing, China;

    Departments of Urology Second Affiliated Hospital, Third Military Medical University, Chongqing, China,Department of Urology Second Affiliated Hospital Third Military Medical University Chongqing 400037 China;

    Departments of Pathology, Second Affiliated Hospital, Third Military Medical University, Chongqing, China;

    Departments of Urology Second Affiliated Hospital, Third Military Medical University, Chongqing, China;

    Departments of Urology Second Affiliated Hospital, Third Military Medical University, Chongqing, China;

    Departments of Urology Second Affiliated Hospital, Third Military Medical University, Chongqing, China;

    Departments of Urology Second Affiliated Hospital, Third Military Medical University, Chongqing, China;

    Departments of Urology Second Affiliated Hospital, Third Military Medical University, Chongqing, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:17:39

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号